AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 49 filers reported holding AC IMMUNE SA in Q4 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $888,000 | +6.0% | 171,813 | 0.0% | 0.03% | 0.0% |
| Q3 2020 | $838,000 | -27.5% | 171,813 | 0.0% | 0.03% | -29.5% |
| Q2 2020 | $1,156,000 | -2.6% | 171,813 | 0.0% | 0.04% | -18.5% |
| Q1 2020 | $1,187,000 | -18.9% | 171,813 | 0.0% | 0.05% | -1.8% |
| Q4 2019 | $1,464,000 | +72.2% | 171,813 | 0.0% | 0.06% | +48.6% |
| Q3 2019 | $850,000 | -10.9% | 171,813 | 0.0% | 0.04% | -5.1% |
| Q2 2019 | $954,000 | +9.9% | 171,813 | 0.0% | 0.04% | +11.4% |
| Q1 2019 | $868,000 | -46.6% | 171,813 | 0.0% | 0.04% | -50.0% |
| Q4 2018 | $1,624,000 | +18.1% | 171,813 | 0.0% | 0.07% | +40.0% |
| Q3 2018 | $1,375,000 | -14.0% | 171,813 | 0.0% | 0.05% | -18.0% |
| Q2 2018 | $1,598,000 | -10.1% | 171,813 | 0.0% | 0.06% | -11.6% |
| Q1 2018 | $1,777,000 | -19.2% | 171,813 | 0.0% | 0.07% | -18.8% |
| Q4 2017 | $2,199,000 | +376.0% | 171,813 | +319.9% | 0.08% | +400.0% |
| Q3 2017 | $462,000 | – | 40,919 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Duquesne Family Office | 1,500,000 | $24,705,000 | 2.18% |
| Monashee Investment Management LLC | 275,000 | $4,529,000 | 1.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 79,800 | $1,314,000 | 0.21% |
| Hillhouse Capital Management | 550,000 | $9,059,000 | 0.18% |
| Temasek Holdings (Private) Ltd | 1,337,500 | $22,029,000 | 0.18% |
| PointState Capital LP | 425,000 | $7,000,000 | 0.07% |
| Artal Group S.A. | 150,000 | $2,471,000 | 0.05% |
| HIGHLAND CAPITAL MANAGEMENT LP | 87,900 | $1,448,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 14,779 | $243,000 | 0.04% |
| Point72 Hong Kong Ltd | 4,000 | $66,000 | 0.04% |